Connect with us

Health

Moffitt researchers discover regulatory pathway that blocks immune response against cancer – EurekAlert

In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby…

Published

on

Article feature image

TAMPA, Fla. – A hallmark of cancer is its ability to evade the immune system. It is why researchers are focused on finding new strategies and targets to jumpstart the immune system so it can mount a response against tumors. One such target is the inhibitory receptor T-cell immunoglobulin and mucin domain 3 (TIM-3), a protein that is overexpressed in many different types of cancer and is associated with poor patient outcomes. It is known to block the activity of immune cells, such as dendritic cells,…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Eating prunes daily can improve risk factors for cardiovascular disease in postmenopausal women – News-Medical.Net
Article feature image
Researchers discover a new mechanism controlling satiation – News-Medical.Net